Failed study sparks debate over drugs derived from fish oil – STAT
TThe results of a new study are reigniting a debate among cardiologists as to whether a prescription fish oil product, Vascepa, reduces the risk of heart attack and stroke in patients. The study does not test Vascepa, made by Amarin Corp., but another drug called Epanova, made by AstraZeneca. But this new trial, called STRENGTH […]
The post Failed study sparks debate over drugs derived from fish…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.